Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings

BACKGROUND: Following testing in clinical trials, the use of remdesivir for treatment of COVID-19 has been authorized for use in parts of the world, including the USA and Europe. Early authorizations were largely based on results from two clinical trials. A third study published by Wang et al. was u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoek, Joyce M., Field, Sarahanne M., de Vries, Ymkje Anna, Linde, Maximilian, Pittelkow, Merle-Marie, Muradchanian, Jasmine, van Ravenzwaaij, Don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301659/
https://www.ncbi.nlm.nih.gov/pubmed/34297766
http://dx.doi.org/10.1371/journal.pone.0255093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301659/
https://www.ncbi.nlm.nih.gov/pubmed/34297766
http://dx.doi.org/10.1371/journal.pone.0255093

Ejemplares similares